Forecasts data is unavailable for this security.
Consensus recommendation
- 16-Nov-23
- 15-Aug-24
- 19-Sep-24
- 17-Oct-24
- 07-Nov-24
Select bar for recommendation details.
Recommendations | 07-Nov-24 | |
---|---|---|
Buy | 1 | |
Outperform | 3 | |
Hold | 4 | |
Sell | 0 | |
Strong Sell | 0 |
Share price forecast in USD
The 5 analysts offering 12 month price targets for Sangamo Therapeutics Inc have a median target of 7.00, with a high estimate of 10.00 and a low estimate of 2.00. The median estimate represents a 186.89% increase from the last price of 2.44.
High | 309.8% | 10.00 |
Med | 186.9% | 7.00 |
Low | -18.0% | 2.00 |
Earnings history & estimates in USD
The next earnings announcement is expected on Mar 11, 2025.
Average growth rate | +32.10% |
Average growth rate | -15.64% |
More ▼
Revenue history & estimates in USD
Average growth rate | +3,399.77% |
Average growth rate | +16.98% |
More ▼